Literature DB >> 6811434

Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.

E C Beuvery, A B Leussink, R W Van Delft, R H Tiesjema, J Nagel.   

Abstract

Adult volunteers were injected with a combined meningococcal group A and group C polysaccharide vaccine. Immunoglobulin M (IgM) and IgG antibody levels against both polysaccharides were measured in serum samples taken 14 days as well as 3 years after vaccination. For both group A and group C polysaccharides, the IgM and IgG antibody levels at 14 days postvaccination were positively related. The IgM-to-IgG antibody ratio at 14 days postvaccination was an indicator for the persistence of both IgM and IgG antibodies during the next 3 years; a high ratio meant a short persistence, whereas a low ratio was associated with a long persistence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811434      PMCID: PMC347572          DOI: 10.1128/iai.37.2.579-585.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Properties of the major component of a peptic digest of rabbit antibody.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN
Journal:  Science       Date:  1960-12-09       Impact factor: 47.728

2.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

3.  Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.

Authors:  M HEIDELBERGER; M M DILAPI; M SIEGEL; A W WALTER
Journal:  J Immunol       Date:  1950-11       Impact factor: 5.422

4.  Secondary IgG responses to type 3 pneumococcal polysaccharide. III. T cell requirement for development of B memory cells.

Authors:  H Braley-Mullen
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

5.  The influence of T cells on the initiation and expression of immunological memory.

Authors:  D W Dresser; A M Popham
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

Review 6.  Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

Authors:  J B Robbins
Journal:  Immunochemistry       Date:  1978-11

7.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

8.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

9.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Authors:  R Schneerson; O Barrera; A Sutton; J B Robbins
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  8 in total

1.  Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.

Authors:  E C Beuvery; F Miedema; R van Delft; J Haverkamp
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

Review 2.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

3.  Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide.

Authors:  E C Beuvery; M H Kayhty; A B Leussink; V Kanhai
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Authors:  J Melancon; R A Murgita; I W Devoe
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay.

Authors:  B D Plikaytis; S H Turner; L L Gheesling; G M Carlone
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

6.  Preparation and physicochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis.

Authors:  E C Beuvery; F Miedema; R W van Delft; J Haverkamp; A B Leussink; B J te Pas; K S Teppema; R H Tiesjema
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.

Authors:  E C Beuvery; R W van Delft; F Miedema; V Kanhai; J Nagel
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  T-cell modulation of the murine antibody response to Neisseria meningitidis group A capsular polysaccharide.

Authors:  E Muller; M A Apicella
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.